Mediwound to present corporate highlights at upcoming investor conferences

Yavne, israel, feb. 23, 2023 (globe newswire) -- mediwound ltd. (nasdaq: mdwd) (the “company”), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced management will present at two upcoming investor conferences in march. details for each is as follows:
MDWD Ratings Summary
MDWD Quant Ranking